At Veraco, we have rapidly established ourselves as a leading partner for the healthcare sector providing cutting-edge innovation that truly makes a difference.
Our commitment to innovation has earned recognition from prestigious organisations collaborating on crucial initiatives like tackling Antimicrobial Resistance (AMR) and Net Zero goals. Furthermore, we were awarded the Business Innovation Award 2024 by UKRI backed innovation incubator Growing Kent and Medway.
Now, Veraco has secured investment from UK based renewable energy leaders Genatec Group.
Genatec CEO David Mack will be taking a minority holding in Veraco and expects to have an active role in its operations, building on his expertise in scaling startups and capitalising on new market opportunities.
Other investors have also shown faith in Veraco’s prospects with the purchase of minority holdings since the start of 2024.
Veraco’s Co-Founder George Strong said: “This is an extremely exciting time for Veraco and we are delighted to welcome Genatec on board. Their expertise and passion align perfectly with our vision, and we look forward to working together to drive growth and innovation.”
Mr Mack added: “I am thrilled to join Veraco at such a pivotal moment in their journey. I look forward to leveraging my experience and skills to help Veraco achieve their aspirations”.
